Prostate Cancer

Highlights in Prostate Cancer From the 2021 European Society for Medical Oncology Congress and the 2021 American Urological Association Meeting

Objective Computerized Cognitive Assessment in Men With Metastatic Castrate-Resistant Prostate Cancer Randomly Receiving Darolutamide or Enzalutamide in the ODENZA Trial The second-generation androgen receptor inhibitor enzalutamide […]

Back to Archive

RT @DrHKantarjian: The field of #BPDCN is rapidly evolving | Our new article by Dr. Pemmaraju @doctorpemm highlights the new era of ta… https://t.co/JSFnWqi49W

11 months ago
RT @ChelseaPinnix: Great summary of the important work that’s been done to improve outcomes in a rare disease. The future is bright.… https://t.co/PmNK5VOwvT

11 months ago
“Blastic Plasmacytoid Dendritic Cell Neoplasm: Emerging Developments and Special Considerations for 2023” by Naveen… https://t.co/EAEfwKrGjU

11 months ago
“Novel Approaches to the Treatment of Multiple Myeloma” by Kathryn T. Maples, PharmD, Sara A. Scott, PharmD, and Sa… https://t.co/9fIXqRSXxe

12 months ago